Live AstraZeneca updates

Live AstraZeneca news coverage of developments with the latest updates. Stay on top of latest AstraZeneca news stories and find out what just happened, what is going on with AstraZeneca. The latest real-time news updates and headlines on AstraZeneca
CARES Phase III Misses Main Goal, Shows Promise for Anselamimab
Imfinzi Wins U.S. Nod for Unique Bladder Cancer Combo
MIT Elects 10 Term, 2 Life Members for 2026
FDA Extends Review for SERENA-6 Camizestrant Data
Datroway Gets US Nod as First-Line Drug for Metastatic TNBC
CHMP Backs Enhertu Approval for HER2+ Metastatic Tumors
CHMP Backs Camizestrant Combo for Advanced Breast Cancer
AstraZeneca Unveils Phase III Cancer, Rare Disease Data
Andexxa Registration Lapses for Factor Xa Reversal
New Plans Advance Rare Disease Treatments
Research: BMI Fails to Capture Full Obesity Health Risks
UK's Largest Business Delegation Launches in LA
UK Drug Shortages Persist, Supply Chain Fixes Insufficient
FDA Clears Enhertu for Two New HER2+ Cancer Uses
Imfinzi Combo Boosts Survival in Bladder Cancer Trial
Eneboparatide Boosts Calcium in Hypoparathyroidism Trial
Research Unveils Better Diagnosis for Missed Heart Condition
Cambridge South Station Opening Date Announced
Needle-Free Flu Vaccine Targets Kids' Immunity Boost
Gut Hormone FGF15 Alters Mice's Weight Loss Response
UK's Biggest Trade Mission Heads to LA
FDA Panel Recommends Truqap for PTEN-Deficient Prostate Cancer
FDA Panel Votes on Camizestrant Combo for HR+ Breast Cancer
New Tool Predicts Genetic Risk for 8 Heart Conditions
Q1 2026 Results
AI Tool Predicts Biological Age, Cancer Prognosis
UK-Shanghai Pact to Boost Healthcare Innovation
Breztri Gains US Nod as First Triple Asthma Therapy
Mail-in Test Boosts Colorectal Cancer Screenings
Saphnelo Autoinjector Approved for Lupus Self-Use in US
Trump Boosts U.S. Manufacturing to 4-Year High
Immunotherapy May Spare Bladder Cancer Patients
Ultomiris Cuts Proteinuria in IgA Nephropathy Trial
CAR T-Cell Therapy Targets High-Risk Smoldering Myeloma
Tozorakimab Hits Primary Goal in COPD Phase III Trial
Early Onset Lung Cancer Linked to Fruits and Grains
Alexion Unveils Leading Rare Disease Data at 2026 AAN
New Flu Vaccine Shows Broad Protection in Mice
Imfinzi Combo Boosts Survival in Unresectable Liver Cancer
Efzimfotase Alfa Shows Positive Phase III Results
New Cholesterol Guideline: What To Know
Cholesterol Guideline Update: Key Points
Tozorakimab Hits Primary Endpoint in COPD Trials
Earlier, Faster, And Fairer Access To New Medicines
AI Model Predicts Liver Cancer Risk From Routine Data
OMP Tops Gartner 2026 Magic Quadrant for Supply Chain
Asthma, COPD Patients to Get Improved Local Care
Imfinzi EU Nod: First Perioperative Immunotherapy